Abstract:Abstract Background Neonatal hypoxic ischemic encephalopathy (HIE) after perinatal asphyxia is a serious clinical condition that may result in permanent neurologic deficits or death. There is an increased incidence of persistent pulmonary hypertension of the newborn (PPHN) in asphyxiated infants. Due to the high disease burden of HIE, studying its altered cardiopulmonary hemodynamics might identify those patients at highest risk for adverse outcome early on. Objectives To investigate the relationship between severity of PPHN and the extent of short-term brain injury in infants with moderate to severe HIE who received therapeutic hypothermia (TH). Design/Methods Retrospective cohort study of 230 TH-treated HIE infants. PPHN was defined and graded clinically and based on echocardiography findings. The primary outcome was the presence of HIE changes on brain MRI and/or death within the first month of life according to the diagnosis and severity of PPHN. Secondary outcomes were the pattern of HIE on brain MRI; abnormal electroencephalogram (EEG) background, clinical, or electrographic seizures, or need for anti-ictal treatment; clinical and laboratory differences between HIE babies with and without PPHN. A logistic regression model was performed to identify PPHN severity as risk factor for moderate-to-severe brain injury or death. Results Brain injury was not found to be different between the two groups according to presence of PPHN whether clinically or based on echocardiography. However, the combined outcome of severe brain injury or death was higher in the clinical PPHN group vs non-PPHN (32.6 vs 22.8%, p=0.014), and early exit from TH due to severe PPHN was associated with the highest mortality (71.4%). Death was found to have a relationship with the severity of PPHN based on echocardiography, with the highest incidence in severe PPHN (36.0 vs 7.7% and 10.0% in the severe, moderate, and mild PPHN groups, respectively, p=0.002). Infants with clinical PPHN were sicker with higher ventilation needs and worse laboratory values compared to those without PPHN. None of the other outcomes were different among the two groups. Conclusion In infants with HIE treated with TH, PPHN was not associated with increased risk of brain injury as evident on MRI, nor clinical or electrographic seizure burden. However, mortality was higher in the most severe PPHN categories.

Hemodynamic response to milrinone for refractory hypoxemia during therapeutic hypothermia for neonatal hypoxic ischemic encephalopathy

Inhaled Nitric Oxide in Preterm and Term Neonates with Hypoxemic Respiratory Failure and Persistent Pulmonary Hypertension

The use of milrinone in neonates with persistent pulmonary hypertension of the newborn - a randomised controlled trial pilot study (MINT 1): study protocol and review of literature

Neonatal Persistent Pulmonary Hypertension Treated with Milrinone: Four Case Reports

Milrinone Versus Sildenafil in Treatment of Neonatal Persistent Pulmonary Hypertension: A Randomized Control Trial

Milrinone in persistent pulmonary hypertension of newborn: a scoping review

The use of milrinone in neonates with persistent pulmonary hypertension of the newborn - a randomised controlled trial pilot study (MINT 1)

Milrinone in the treatment of Persistent Pulmonary Hypertension of the Newborn: A Case Series

Improved mortality and haemodynamics with milrinone in cardiogenic shock due to acute decompensated heart failure

Systemic tolerance of intravenous milrinone administration for cerebral vasospasm secondary to non-traumatic subarachnoid hemorrhage

Hemodynamic response and clinical outcome following intravenous milrinone plus norepinephrine–based hyperdynamic hypertensive therapy in patients suffering secondary cerebral ischemia after aneurysmal subarachnoid hemorrhage

Comparison of the efficacy of inhaled versus infused milrinone in the management of persistent pulmonary hypertension of the newborn in resource‐limited settings: A randomized clinical trial

The Hemodynamic Effects of Milrinone in Patients with Sepsis and Low Cardiac Output

Milrinone vs Dobutamine for the Management of Cardiogenic Shock: Implications of Renal Function and Injury

Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock.

pCO2 values in asphyxiated infants under therapeutic hypothermia after tailored respiratory management: a retrospective cohort study

Prevention of Low Cardiac Output Syndrome After Pediatric Cardiac Surgery: A Double-Blind Randomized Clinical Pilot Study Comparing Dobutamine and Milrinone

24 Persistent pulmonary hypertension and short-term neurological outcomes in infants with hypoxic ischemic encephalopathy undergoing therapeutic hypothermia

In-hospital outcomes of neonates with hypoxic-ischemic encephalopathy receiving extracorporeal membrane oxygenation

Milrinone effects on cardiac mitochondria, hemodynamics, and death in catecholamine-infused rats

Pulmonary vasodilator strategies in neonates with acute hypoxemic respiratory failure and pulmonary hypertension